All In Biotech

Free tool

FAERS Monitor: Novolog Penfill

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020986 or its brand name (Novolog Penfill, Insulin Aspart Recombinant). Reports on generic versions are filed under their own applications.

Reports

61,414

Serious

38,468

63% of reports

Hospitalization

20,463

Death reported

4,442

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased9,657
  • nausea3,691
  • drug ineffective3,180
  • blood glucose decreased3,122
  • fatigue2,601
  • diarrhoea2,554
  • dyspnoea2,528
  • vomiting2,383
  • off label use2,041
  • dizziness1,927
  • fall1,784
  • headache1,776
  • death1,755
  • weight decreased1,743
  • pain1,737

Reports by year received

View as table
YearReports
2004192
2005397
2006808
2007915
2008816
20091,421
20101,195
20111,413
20121,495
20131,789
20142,349
20154,610
20164,867
20174,720
20185,250
20194,672
20204,356
20213,829
20223,401
20232,956
20243,264
20254,053
20262,646

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,992,745 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal3,12223.722.963,720
blood glucose increasedSignal9,65718.418.1152,544
weight decreasedSignal1,7432.12.01,072
fall1,7841.81.8691
vomiting2,3831.71.7762
nausea3,6911.61.6858
dyspnoea2,5281.51.5477
diarrhoea2,5541.41.3245
dizziness1,9271.31.3156
fatigue2,6011.11.149
headache1,7761.00.92
pain1,7371.00.92
drug ineffective3,1800.80.8124
off label use2,0410.80.8109
death1,7550.70.7240

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.